This paper contains the analysis of pharmaceutical companies of the developed and the developing countries, mainly focusing the worst condition of the South Africa. The paper discusses the role of the pharmaceutical companies in drugs distribution, the principal arguments of pharmaceutical companies opposing IPR laws, the duties on drugs distributed by the Western Unions to the South Africa, the extension of the transition period for the patent protection of pharmaceuticals to the LCDs, the impacts of relaxation in IPR Rules on the developing countries and the role of MNCs in providing funds to the developing countries.
Abstractii
Introduction1
Answer: 11
Role of the Pharmaceutical Companies in Drugs Distribution1
Answer: 23
Principal Arguments of Pharmaceutical Companies Opposing IPR Laws3
Answer: 35
Duties on Drugs Distributed by the Western Unions to the South Africa5
Answer: 47
Extension of the Transition Period for the Patent Protection of Pharmaceuticals7
Answer: 59
Impacts of Relaxation in IPR Rules on the Developing Countries9
Answer: 610
Role of MNCs in Providing Funds to the Developing Countries10
Conclusion11
References12
Pharmaceutical Companies and Global Aid Epidemic
Introduction
This paper examines the pharmaceutical industry of the developed and the developing countries in term of their health sectors and their infrastructure. The pharmaceutical companies of the developed countries are proficient and skilled in approaching the technologically advanced methods of treatment of the intensely severe diseases that are life-threatening. On the other side, the developing countries are not financially strong to invest much finance in the manufacturing of the drugs and vaccinations neither they can import the high cost drugs form the multi-national companies (Anonymous, 2007).
Therefore, these needs of the developing countries require the implication of certain laws governing their rights, on the basis of morality and social norms. There is a great involvement of WHO in this regard in order to ensure the aid towards these issues of developing countries. However, the low pricing demand of the developing countries cannot be entertained by the developed countries as they have to cop their revenues for the high amount of investment on the manufacturing of the drugs. Therefore, these countries limit the provision of support to these developing countries by somehow varying the quality; thus, lowering the prices of the drugs (Mthombeni, 2006).
Answer: 1
Role of the Pharmaceutical Companies in Drugs Distribution
Pharmaceutical companies hold the responsibility of distributing drugs to the developing countries. This availability requires being at low cost or almost freely so that the poor people suffering from disorders and diseases may avail the facility for saving their lives. It carries the economic, political and mainly the moral sense in the society. The main theme is to provide these drugs to the people of developing countries as there is a great proportion of people suffering from the epidemic of HIV/AIDS, which requires a definite treatment. The case study of South Africa provides the facts that the country suffers greatly from the effects of HIV/AIDS in a way that one among four adults are suffering from this disease. It incorporates almost 95percent of the population of the countries that are in developing stage (Mthombeni, ...